trending Market Intelligence /marketintelligence/en/news-insights/trending/n7ddet9qak3oabxc08wdya2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Carlyle acquires minority stake in Ambio Holdings

Banking Essentials Newsletter December Edition Part 2

Banking Essentials Newsletter - November Edition

University Essentials | COVID-19 Economic Outlook in Banking: Rates and Long-Term Expectations: Q&A with the Experts

Estimating Credit Losses Under COVID-19 and the Post-Crisis Recovery

Carlyle acquires minority stake in Ambio Holdings

Carlyle Group LP, a global alternative asset manager, bought a "significant" minority stake in biotechnology company Ambio Holdings Inc. from MVM Partners LLP, a healthcare-focused private equity firm.

Carlyle made the acquisition in Ambio, which produces peptides for drugs approved by U.S., Chinese and European agencies, via its Carlyle Asia Partners V, a $6.55 billion fund for buyout and strategic investments in the Asia-Pacific region.

MVM still holds a significant interest in Ambio Holdings.

The terms of the transaction were not disclosed.

The asset management firm had invested more than $11.5 billion in the global healthcare industry, with an estimated $1.5 billion spent on healthcare companies in Asia as of June 30.